( NASDAQ-NMS:ANIP,NASDAQ-NMS:BPAX )

News from ani pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 28, 2016, 08:30 ET ANI Pharmaceuticals Announces Launch of Hydroxyprogesterone Caproate Injection USP, 250mg/mL

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the commercial launch of Hydroxyprogesterone Caproate Injection ("HPC") USP...


Jun 13, 2016, 08:00 ET ANI Pharmaceuticals Announces Launch of Oxycodone Capsules, 5mg

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the commercial launch of Oxycodone HCl Capsules, 5mg.  Trailing twelve-month...


May 23, 2016, 08:30 ET ANI Announces Appointment of Mark J. Ginski Ph.D as Vice President Corticotropin Product Development

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the appointment of Mark Ginski Ph.D as Vice President Corticotropin Product...


May 18, 2016, 08:00 ET ANI Pharmaceuticals to Present at the UBS Global Healthcare Conference

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that it will present on May 23, 2016 at the UBS Global Healthcare Conference at the Grand...


May 17, 2016, 09:00 ET ANI Pharmaceuticals Enters Into Exclusive Distribution and Supply Agreement for Hydroxyprogesterone Caproate Injection USP

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the signing of an exclusive distribution and supply agreement with Aspen...


May 13, 2016, 09:00 ET ANI Pharmaceuticals Enters Three Year $30 Million Asset Based Line of Credit with Citizens Bank

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has entered a new three year senior secured asset-based revolving...


May 09, 2016, 08:00 ET ANI Pharmaceuticals Announces Launch of 50mg and 150mg Fenofibrate Capsules in ANI label

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the commercial launch of 50mg and 150mg fenofibrate capsules USP (the...


May 05, 2016, 08:00 ET ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2016 Highlights and Reaffirms Updated Guidance

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2016, and reaffirmed...


Apr 27, 2016, 08:05 ET ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2016 Financial Results and Reaffirm Guidance

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2016 financial results and...


Apr 27, 2016, 08:00 ET ANI Announces Appointment of Stephen P. Carey as Vice President and Chief Financial Officer

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the appointment of Stephen P. Carey to the position of Vice President and Chief...


Apr 05, 2016, 08:05 ET ANI Pharmaceuticals Announces FDA Approval of Oxycodone Capsules, 5mg

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration...


Apr 04, 2016, 08:05 ET ANI Pharmaceuticals Updates 2016 Financial Guidance

 As a result of the close of the acquisition of the Inderal® LA assets from Cranford Pharmaceuticals, ANI Pharmaceuticals, Inc. ("ANI")...


Apr 04, 2016, 08:00 ET ANI Pharmaceuticals Closes Acquisition of Inderal® LA Assets

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has completed the acquisition of the portfolio of Inderal® LA...


Mar 11, 2016, 08:00 ET ANI Pharmaceuticals Agrees to Acquire Inderal® LA Assets from Cranford Pharmaceuticals

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has agreed to acquire a portfolio of Inderal® LA assets from...


Mar 09, 2016, 08:00 ET ANI Pharmaceuticals to Present at 28th Annual ROTH Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that it will present at the 28th Annual ROTH Conference at the Ritz-Carlton at Laguna...


Feb 16, 2016, 08:00 ET ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2015 Financial Results and 2016 Guidance

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2015 financial...


Feb 01, 2016, 08:00 ET ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million

 ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired the exclusive rights to distribute 1% and 2.5%...


Dec 29, 2015, 08:00 ET ANI Pharmaceuticals Announces Launch of Flecainide Tablets

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the commercial launch of Flecainide Acetate 50mg, 100mg, and 150mg tablets....


Dec 17, 2015, 08:00 ET ANI Pharmaceuticals Announces FDA Approval of Polyethylene Glycol 3350 Powder for Oral Solution, 17mg/Scoopful

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of...


Dec 08, 2015, 08:00 ET ANI Pharmaceuticals Presents At Oppenheimer 26th Annual Healthcare Conference

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present today at the Oppenheimer & Co. 26th Annual Healthcare Conference at the Westin Grand...


Nov 03, 2015, 08:00 ET ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2015 Results and Highlights

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2015 and...


Nov 02, 2015, 08:00 ET ANI Pharmaceuticals Announces Launch of Vancomycin Capsules

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Vancomycin HCl 125mg and 250mg capsules indicated for treatment of...


Oct 27, 2015, 08:00 ET ANI Pharmaceuticals Schedules Conference Call for Third Quarter and Year-to-Date 2015 Financial Results

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2015 financial...


Oct 16, 2015, 08:00 ET ANI Pharmaceuticals Announces Launch of Oxycodone Hydrochloride Oral Solution

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Oxycodone Hydrochloride Oral Solution 5mg/5mL indicated for...


Oct 13, 2015, 08:00 ET ANI Pharmaceuticals Appoints Peter A. Lankau to Its Board of Directors

 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) announced today the appointment of Peter A. Lankau to the Company's Board of Directors to...